Diversified Healthcare Analyst Ratings
Diversified Healthcare Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B. Riley Securities | $4 → $4.5 | Maintains | Buy |
12/30/2021 | 128.14% | B. Riley Securities | $5 → $6 | Maintains | Buy |
07/29/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
03/15/2021 | 90.11% | Morgan Stanley | $4.75 → $5 | Maintains | Equal-Weight |
02/02/2021 | 80.61% | Morgan Stanley | $5 → $4.75 | Maintains | Equal-Weight |
11/16/2020 | 23.57% | B of A Securities | $2.75 → $3.25 | Maintains | Underperform |
10/09/2020 | 14.07% | Morgan Stanley | $2.75 → $3 | Maintains | Equal-Weight |
06/22/2020 | 52.09% | Wells Fargo | $3.5 → $4 | Maintains | Equal-Weight |
06/08/2020 | — | JMP Securities | Reinstates | → Market Perform | |
05/19/2020 | 4.56% | Morgan Stanley | $8 → $2.75 | Maintains | Equal-Weight |
05/11/2020 | 166.16% | B. Riley Securities | $10 → $7 | Maintains | Buy |
03/04/2020 | 280.23% | B. Riley Securities | $12 → $10 | Maintains | Buy |
01/17/2020 | 242.21% | Wells Fargo | → $9 | Downgrades | Overweight → Equal-Weight |
日期 | 上行/下行 | 分析公司 | 目標價格變化 | 評級變化 | 上一次/當前評級 |
---|---|---|---|---|---|
09/05/2023 | 71.1% | B.萊利證券 | $4→$4.5 | 維護 | 買 |
2021年12月30日 | 128.14% | B.萊利證券 | $5→$6 | 維護 | 買 |
07/29/2021 | 80.61% | 摩根士丹利 | $5→$4.75 | 維護 | 等重 |
03/15/2021 | 90.11% | 摩根士丹利 | $4.75→$5 | 維護 | 等重 |
02/02/2021 | 80.61% | 摩根士丹利 | $5→$4.75 | 維護 | 等重 |
11/16/2020 | 23.57% | B of A證券 | $2.75→$3.25 | 維護 | 表現不佳 |
10/09/2020 | 14.07% | 摩根士丹利 | $2.75→$3 | 維護 | 等重 |
06/22/2020 | 52.09% | 富國銀行 | $3.5→$4 | 維護 | 等重 |
06/08/2020 | - | JMP證券 | 恢復 | →市場表現 | |
2020/05/19 | 4.56% | 摩根士丹利 | $8→$2.75 | 維護 | 等重 |
05/11/2020 | 166.16% | B.萊利證券 | $10→$7 | 維護 | 買 |
03/04/2020 | 280.23% | B.萊利證券 | $12→$10 | 維護 | 買 |
2020/01/17 | 242.21% | 富國銀行 | →$9 | 評級下調 | 超重→等重 |
What is the target price for Diversified Healthcare (DHC)?
多元化醫療(DHC)的目標價格是多少?
The latest price target for Diversified Healthcare (NASDAQ: DHC) was reported by B. Riley Securities on September 5, 2023. The analyst firm set a price target for $4.50 expecting DHC to rise to within 12 months (a possible 71.10% upside). 1 analyst firms have reported ratings in the last year.
B·萊利證券於2023年9月5日報道了多元化醫療(納斯達克:DHC)的最新目標價。這家分析公司將目標價定為4.50美元,預計DHC將在12個月內上漲至71.10%。1家分析公司在過去一年公佈了評級。
What is the most recent analyst rating for Diversified Healthcare (DHC)?
多元化醫療(DHC)的最新分析師評級是多少?
The latest analyst rating for Diversified Healthcare (NASDAQ: DHC) was provided by B. Riley Securities, and Diversified Healthcare maintained their buy rating.
分析師對多元化醫療(納斯達克:DHC)的最新評級由B.萊利證券提供,多元化醫療維持買入評級。
When is the next analyst rating going to be posted or updated for Diversified Healthcare (DHC)?
多元化醫療(DHC)的下一次分析師評級將於何時發佈或更新?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Diversified Healthcare, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Diversified Healthcare was filed on September 5, 2023 so you should expect the next rating to be made available sometime around September 5, 2024.
分析師在進行了廣泛的研究後得出股票評級,其中包括查閱公共財務報表,與Diversified Healthcare的高管和客戶交談,以及聽取收益電話會議。大多數分析師每三個月就會這樣做一次,所以你每年應該會得到每家公司每家公司的4個評級。對多元化醫療的上一次評級是在2023年9月5日提交的,所以你應該預計下一次評級將在2024年9月5日左右的某個時候公佈。
Is the Analyst Rating Diversified Healthcare (DHC) correct?
分析師對多元化醫療(DHC)的評級正確嗎?
While ratings are subjective and will change, the latest Diversified Healthcare (DHC) rating was a maintained with a price target of $4.00 to $4.50. The current price Diversified Healthcare (DHC) is trading at is $2.63, which is out of the analyst's predicted range.
雖然評級是主觀的,並將發生變化,但最新的多元化醫療(DHC)評級保持不變,目標價在4.00美元至4.50美元之間。多元化醫療(DHC)目前的交易價格為2.63美元,超出了分析師的預測區間。